Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy
- 1 February 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (3) , 862-872
Abstract
Cellular Src (c-Src) integrates a large number of signal transduction pathways regulating cell division, migration, and other aspects of cell physiology. Mutations of Src kinase have not been described in human prostate cancer, but evidence for increased levels of expression accompanying cancer progression has been reported. We analyzed overexpression of c-Src in naïve mouse prostate epithelium and observed no change in tubule formation frequency or histologic structure. However, when enhanced c-Src expression is coupled with enhanced expression of androgen receptor (AR), it results in a strong activation of Src kinase activity accompanied by activation of the MAPK pathway, and enhanced AR activity. Similar to the pathology induced by constitutively active c-Src(Y529F), the tubules progress to frank carcinoma with invasion and display markers of epithelial-to-mesenchymal transition. These combined results suggest that nonmutated Src kinase may play a more important role in the genesis and progression of prostate cancer than previously appreciated and that epigenetic changes that enhance the level of AR may select for enhanced expression of c-Src with accompanying activation and a strong drive to malignant progression. Cancer Res; 71(3); 862–72. ©2010 AACR.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancerExpert Opinion on Investigational Drugs, 2010
- Docetaxel-based combination therapy for castration-resistant prostate cancerAnnals of Oncology, 2010
- A renaissance for SRCNature Reviews Cancer, 2004
- In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchymeProceedings of the National Academy of Sciences, 2003
- Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancerCancer Cell, 2003
- The EZH2 polycomb transcriptional repressor—a marker or mover of metastatic prostate cancer?Cancer Cell, 2002
- Src Catalytic but Not Scaffolding Function Is Needed for Integrin-Regulated Tyrosine Phosphorylation, Cell Migration, and Cell SpreadingMolecular and Cellular Biology, 2002
- The hunting of the SrcNature Reviews Molecular Cell Biology, 2001
- Lack of Activating c-SRC Mutations at Codon 531 in Rectal CancerCancer Genetics and Cytogenetics, 2000
- Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptorNature Medicine, 2000